Jacob D. Palmer

Jacob D. Palmer

Auto-generated profile, based on publicly available information

Jacob D. Palmer

Affiliations Department of Biological Sciences, Binghamton University, Binghamton, New York, United States of America, Binghamton Biofilm Research Center, Binghamton University, Binghamton, New York, United States of America

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JPJacob D. Palmer
Jacob D. Palmer
EPEmma Piattelli
Emma Piattelli
BMBeth A. McCormick
Beth A. McCormick
MSMark W. Silby
Mark W. Silby
CBChristopher J. Brigham
Christopher J. Brigham
VBVanni Bucci
Vanni Bucci

29 September 2022 in Gut Microbes
Verified
Journal Article
Open access
BMBenedikt M. M Mortzfeld
Benedikt M. M Mortzfeld
JPJacob D. Palmer
Jacob D. Palmer
SBShakti K. Bhattarai
Shakti K. Bhattarai
HDHaley L. Dupre
Haley L. Dupre
RMRegino Mercado-Lubio
Regino Mercado-Lubio
VBVanni Bucci
Vanni Bucci
The gastrointestinal (GI) tract is the reservoir for multidrug resistant (MDR) pathogens, specifically carbapenem-resistant (CR) Klebsiella pneumoniae and other Enterobacteriaceae, which often lead to the spread of antimicrobial resistance genes, severe extraintestinal infections, and lethal outcomes. Selective GI decolonization has been proposed as a new strategy for preventing transmission to other body sites and minimizing spreading to susceptible individuals. Here, we purify the to-date uncharacterized class IIb microcin I47 (MccI47) and demonstrate potent inhibition of numerous Enterobacteriaceae, including multidrug-resistant clinical isolates, in vitro at concentrations resembling those of commonly prescribed antibiotics. We then genetically modify the probiotic bacterium Escherichia coli Nissle 1917 (EcN) to produce MccI47 from a stable multicopy plasmid by using MccI47 toxin production in a counterselection mechanism to engineer one of the native EcN plasmids, which renders provisions for inducible expression and plasmid selection unnecessary. We then test the clinical relevance of the MccI47-producing engineered EcN in a murine CR K. pneumoniae colonization model and demonstrate significant MccI47-dependent reduction of CR K. pneumoniae abundance after seven days of daily oral live biotherapeutic administration without disruption of the resident microbiota. This study provides the first demonstration of MccI47 as a potent antimicrobial against certain Enterobacteriaceae, and its ability to significantly reduce the abundance of CR K. pneumoniae in a preclinical animal model, when delivered from an engineered live biotherapeutic product. This study serves as the foundational step toward the use of engineered live biotherapeutic products aimed at the selective removal of MDR pathogens from the GI tract.

13 September 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JPJacob D. Palmer
Jacob D. Palmer
KFKevin R. Foster
Kevin R. Foster
A key property of many antibiotics is that they will kill or inhibit a diverse range of microbial species. This broad-spectrum of activity has its evolutionary roots in ecological competition, whereby bacteria and other microbes use antibiotics to suppress other strains and species. However, many bacteria also use narrow-spectrum toxins, such as bacteriocins, that principally target conspecifics. Why has such a diversity in spectrum evolved? Here, we develop an evolutionary model to understand antimicrobial spectrum. Our first model recapitulates the intuition that broad-spectrum is best, because it enables a microbe to kill a wider diversity of competitors. However, this model neglects an important property of antimicrobials: They are commonly bound, sequestered, or degraded by the cells they target. Incorporating this toxin loss reveals a major advantage to narrow-spectrum toxins: They target the strongest ecological competitor and avoid being used up on less important species. Why then would broad-spectrum toxins ever evolve? Our model predicts that broad-spectrum toxins will be favored by natural selection if a strain is highly abundant and can overpower both its key competitor and other species. We test this prediction by compiling and analyzing a database of the regulation and spectrum of toxins used in inter-bacterial competition. This analysis reveals a strong association between broad-spectrum toxins and density-dependent regulation, indicating that they are indeed used when strains are abundant. Our work provides a rationale for why bacteria commonly evolve narrow-spectrum toxins such as bacteriocins and suggests that the evolution of antibiotics proper is a signature of ecological dominance.

25 February 2020 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JPJacob D. Palmer
Jacob D. Palmer
BMBenedikt M. M Mortzfeld
Benedikt M. M Mortzfeld
EPEmma Piattelli
Emma Piattelli
MSMark W. Silby
Mark W. Silby
BMBeth A. McCormick
Beth A. McCormick
VBVanni Bucci
Vanni Bucci

1 April 2016 in Renewable and Sustainable Energy Reviews
Verified
Journal Article
Closed access
JPJacob D. Palmer
Jacob D. Palmer
CBChristopher J. Brigham
Christopher J. Brigham

12 April 2021 in microLife
Verified
Journal Article
Open access
PDF file
OCOlivier Cunrath
Olivier Cunrath
JPJacob D Palmer
Jacob D Palmer
Nutritional immunity is a powerful strategy at the core of the battlefield between host survival and pathogen proliferation. A host can prevent pathogens from accessing biological metals such as Mg, Fe, Zn, Mn, Cu, Co or Ni, or actively intoxicate them with metal overload. While the importance of metal homeostasis for the enteric pathogen Salmonella enterica Typhimurium was demonstrated many decades ago, inconsistent results across various mouse models, diverse Salmonella genotypes, and differing infection routes challenge aspects of our understanding of this phenomenon. With expanding access to CRISPR-Cas9 for host genome manipulation, it is now pertinent to re-visit past results in the context of specific mouse models, identify gaps and incongruities in current knowledge landscape of Salmonella homeostasis, and recommend a straight path forward towards a more universal understanding of this historic host–microbe relationship.